Ranbaxy Balance Sheet 2u116j
This document was ed by and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this report form. Report 3i3n4
Overview 26281t
& View Ranbaxy Balance Sheet as PDF for free.
More details 6y5l6z
- Words: 605
- Pages: 5
Balance Sheet of Ranbaxy Laboratories
------------------- in Rs. Cr. ------------------Mar '14
Dec '12
Dec '11
Dec '10
Dec '09
15 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
211.66
211.46
211.00
210.52
210.21
Equity Share Capital
211.66
211.46
211.00
210.52
210.21
0.50
1.11
0.67
6.60
175.85
Sources Of Funds
Share Application Money Preference Share Capital
0.00
0.00
0.00
0.00
0.00
Reserves
884.83
1,709.51
1,713.16
4,915.28
3,748.54
Networth
1,096.99
1,922.08
1,924.83
5,132.40
4,134.60
Secured Loans
1,011.75
944.18
229.59
195.39
175.83
Unsecured Loans
4,979.31
3,819.43
3,653.82
4,065.33
3,172.55
Total Debt
5,991.06
4,763.61
3,883.41
4,260.72
3,348.38
Total Liabilities
7,088.05
6,685.69
5,808.24
9,393.12
7,482.98
Mar '14
Dec '12
Dec '11
Dec '10
Dec '09
15 mths
12 mths
12 mths
12 mths
12 mths
3,337.81
3,118.22
2,886.15
2,857.63
2,620.92
Application Of Funds Gross Block Less: Revaluation Reserves
0.00
0.00
0.00
0.00
0.00
Less: Accum. Depreciation
1,325.67
1,124.69
1,019.15
1,145.52
1,027.52
Net Block
2,012.14
1,993.53
1,867.00
1,712.11
1,593.40
183.63
159.60
209.12
330.18
414.92
INVESTMENTS
4,080.88
3,131.17
3,410.79
3,804.44
3,833.69
Inventories
1,695.14
1,731.84
1,655.23
1,489.91
1,230.48
Sundry Debtors
1,237.47
1,435.89
3,682.82
1,292.63
1,534.65
Capital Work in Progress
Cash and Bank Balance
790.57
2,834.77
1,937.95
22.44
25.56
Total Current Assets
3,723.18
6,002.50
7,276.00
2,804.98
2,790.69
Loans and Advances
3,105.21
1,683.14
1,558.01
1,470.45
1,967.65
0.00
0.00
0.00
2,689.85
728.56
6,828.39
7,685.64
8,834.01
6,965.28
5,486.90
Fixed Deposits Total CA, Loans & Advances Deferred Credit Current Liabilities Provisions
0.00
0.00
0.00
0.00
0.00
5,696.72
3,227.24
5,583.81
2,491.08
3,082.89
320.26
3,057.02
2,928.87
927.82
763.03
6,016.98
6,284.26
8,512.68
3,418.90
3,845.92
811.41
1,401.38
321.33
3,546.38
1,640.98
0.00
0.00
0.00
0.00
0.00
Total Assets
7,088.06
6,685.68
5,808.24
9,393.11
7,482.99
Contingent Liabilities
1,222.20
789.63
927.85
276.13
261.05
25.87
45.42
45.60
121.74
94.16
Total CL & Provisions Net Current Assets Miscellaneous Expenses
Book Value (Rs)
Profit & Loss of Ranbaxy Laboratories Profit & loss
Mar '14
Dec '12
------------------- in Rs. Cr. ------------------Dec '11
Dec '10
Dec
15 mths
12 mths
12 mths
12 mths
12 mt
6,864.94
6,303.54
7,799.06
5,687.33
4,797.
0.00
0.00
0.00
40.96
15.
6,864.94
6,303.54
7,799.06
5,646.37
4,781.
303.28
-124.07
-3,549.63
562.45
485.
Income Sales Turnover Excise Duty Net Sales Other Income Stock Adjustments Total Income
175.12
49.25
135.72
161.43
33.
7,343.34
6,228.72
4,385.15
6,370.25
5,301.
3,182.54
2,453.09
2,523.08
2,181.22
1,916.
304.27
230.91
194.98
132.75
109.
Expenditure Raw Materials Power & Fuel Cost Employee Cost
1,274.73
1,019.59
860.71
608.28
582.
Other Manufacturing Expenses
0.00
0.00
0.00
96.68
89.
Selling and Expenses
0.00
0.00
0.00
1,332.70
1,306.
2,603.01
2,206.28
3,281.97
185.14
158.
0.00
0.00
0.00
0.00
0.
7,364.55
5,909.87
6,860.74
4,536.77
4,162.
Mar '14
Dec '12
Dec '11
Dec '10
Dec '
15 mths
12 mths
12 mths
12 mths
12 mt
-324.49
442.92
1,074.04
1,271.03
652.
PBDIT
-21.21
318.85
-2,475.59
1,833.48
1,138.
Interest
547.05
296.98
299.00
54.19
39.
-568.26
21.87
-2,774.59
1,779.29
1,098.
280.17
186.16
274.08
228.35
148.
Other Written Off
0.00
0.00
0.00
0.00
0.
Profit Before Tax
-848.43
-164.29
-3,048.67
1,550.94
950.
0.00
0.00
0.00
21.88
111.
Miscellaneous Expenses Preoperative Exp Capitalised Total Expenses
Operating Profit
PBDT Depreciation
Extra-ordinary items
PBT (Post Extra-ord Items) Tax
-848.43
-164.29
-3,048.67
1,572.82
1,062.
30.57
-1.94
3.38
415.48
488.
Reported Net Profit
-879.00
-162.34
-3,052.05
1,148.73
571.
Total Value Addition
4,182.01
3,456.78
4,337.66
2,355.55
2,246.
Preference Dividend
0.00
0.00
0.00
0.00
0.
Equity Dividend
0.00
0.00
0.00
84.21
0.
Corporate Dividend Tax
0.00
0.00
0.00
13.99
0.
4,237.79
4,229.14
4,220.00
4,210.41
4,204.
-20.74
-3.84
-72.32
27.28
13.
Per share data (annualised) Shares in issue (lakhs) Earning Per Share (Rs) Equity Dividend (%) Book Value (Rs)
Source : Dion Global Solutions Limited
0.00
0.00
0.00
40.00
0.
25.87
45.42
45.60
121.74
94.
BSE
NSE
------------------- in Rs. Cr. ------------------Mar '14
Dec '12
Dec '11
Dec '10
Dec '09
15 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
211.66
211.46
211.00
210.52
210.21
Equity Share Capital
211.66
211.46
211.00
210.52
210.21
0.50
1.11
0.67
6.60
175.85
Sources Of Funds
Share Application Money Preference Share Capital
0.00
0.00
0.00
0.00
0.00
Reserves
884.83
1,709.51
1,713.16
4,915.28
3,748.54
Networth
1,096.99
1,922.08
1,924.83
5,132.40
4,134.60
Secured Loans
1,011.75
944.18
229.59
195.39
175.83
Unsecured Loans
4,979.31
3,819.43
3,653.82
4,065.33
3,172.55
Total Debt
5,991.06
4,763.61
3,883.41
4,260.72
3,348.38
Total Liabilities
7,088.05
6,685.69
5,808.24
9,393.12
7,482.98
Mar '14
Dec '12
Dec '11
Dec '10
Dec '09
15 mths
12 mths
12 mths
12 mths
12 mths
3,337.81
3,118.22
2,886.15
2,857.63
2,620.92
Application Of Funds Gross Block Less: Revaluation Reserves
0.00
0.00
0.00
0.00
0.00
Less: Accum. Depreciation
1,325.67
1,124.69
1,019.15
1,145.52
1,027.52
Net Block
2,012.14
1,993.53
1,867.00
1,712.11
1,593.40
183.63
159.60
209.12
330.18
414.92
INVESTMENTS
4,080.88
3,131.17
3,410.79
3,804.44
3,833.69
Inventories
1,695.14
1,731.84
1,655.23
1,489.91
1,230.48
Sundry Debtors
1,237.47
1,435.89
3,682.82
1,292.63
1,534.65
Capital Work in Progress
Cash and Bank Balance
790.57
2,834.77
1,937.95
22.44
25.56
Total Current Assets
3,723.18
6,002.50
7,276.00
2,804.98
2,790.69
Loans and Advances
3,105.21
1,683.14
1,558.01
1,470.45
1,967.65
0.00
0.00
0.00
2,689.85
728.56
6,828.39
7,685.64
8,834.01
6,965.28
5,486.90
Fixed Deposits Total CA, Loans & Advances Deferred Credit Current Liabilities Provisions
0.00
0.00
0.00
0.00
0.00
5,696.72
3,227.24
5,583.81
2,491.08
3,082.89
320.26
3,057.02
2,928.87
927.82
763.03
6,016.98
6,284.26
8,512.68
3,418.90
3,845.92
811.41
1,401.38
321.33
3,546.38
1,640.98
0.00
0.00
0.00
0.00
0.00
Total Assets
7,088.06
6,685.68
5,808.24
9,393.11
7,482.99
Contingent Liabilities
1,222.20
789.63
927.85
276.13
261.05
25.87
45.42
45.60
121.74
94.16
Total CL & Provisions Net Current Assets Miscellaneous Expenses
Book Value (Rs)
Profit & Loss of Ranbaxy Laboratories Profit & loss
Mar '14
Dec '12
------------------- in Rs. Cr. ------------------Dec '11
Dec '10
Dec
15 mths
12 mths
12 mths
12 mths
12 mt
6,864.94
6,303.54
7,799.06
5,687.33
4,797.
0.00
0.00
0.00
40.96
15.
6,864.94
6,303.54
7,799.06
5,646.37
4,781.
303.28
-124.07
-3,549.63
562.45
485.
Income Sales Turnover Excise Duty Net Sales Other Income Stock Adjustments Total Income
175.12
49.25
135.72
161.43
33.
7,343.34
6,228.72
4,385.15
6,370.25
5,301.
3,182.54
2,453.09
2,523.08
2,181.22
1,916.
304.27
230.91
194.98
132.75
109.
Expenditure Raw Materials Power & Fuel Cost Employee Cost
1,274.73
1,019.59
860.71
608.28
582.
Other Manufacturing Expenses
0.00
0.00
0.00
96.68
89.
Selling and Expenses
0.00
0.00
0.00
1,332.70
1,306.
2,603.01
2,206.28
3,281.97
185.14
158.
0.00
0.00
0.00
0.00
0.
7,364.55
5,909.87
6,860.74
4,536.77
4,162.
Mar '14
Dec '12
Dec '11
Dec '10
Dec '
15 mths
12 mths
12 mths
12 mths
12 mt
-324.49
442.92
1,074.04
1,271.03
652.
PBDIT
-21.21
318.85
-2,475.59
1,833.48
1,138.
Interest
547.05
296.98
299.00
54.19
39.
-568.26
21.87
-2,774.59
1,779.29
1,098.
280.17
186.16
274.08
228.35
148.
Other Written Off
0.00
0.00
0.00
0.00
0.
Profit Before Tax
-848.43
-164.29
-3,048.67
1,550.94
950.
0.00
0.00
0.00
21.88
111.
Miscellaneous Expenses Preoperative Exp Capitalised Total Expenses
Operating Profit
PBDT Depreciation
Extra-ordinary items
PBT (Post Extra-ord Items) Tax
-848.43
-164.29
-3,048.67
1,572.82
1,062.
30.57
-1.94
3.38
415.48
488.
Reported Net Profit
-879.00
-162.34
-3,052.05
1,148.73
571.
Total Value Addition
4,182.01
3,456.78
4,337.66
2,355.55
2,246.
Preference Dividend
0.00
0.00
0.00
0.00
0.
Equity Dividend
0.00
0.00
0.00
84.21
0.
Corporate Dividend Tax
0.00
0.00
0.00
13.99
0.
4,237.79
4,229.14
4,220.00
4,210.41
4,204.
-20.74
-3.84
-72.32
27.28
13.
Per share data (annualised) Shares in issue (lakhs) Earning Per Share (Rs) Equity Dividend (%) Book Value (Rs)
Source : Dion Global Solutions Limited
0.00
0.00
0.00
40.00
0.
25.87
45.42
45.60
121.74
94.
BSE
NSE
Related Documents 3h463d
Ranbaxy Balance Sheet 2u116j
December 2019 60
Ranbaxy 4j7r
November 2019 48
Business-balance-sheet-template.xls 4na2f
November 2019 58
Balance Sheet Analysis 1r86z
August 2021 0
Itc Balance Sheet 65395m
November 2022 0
Balance Sheet Template Xls 5x5r5m
December 2022 0More Documents from "nawaz" 2s3y3j
Fst-1 (foundation Course In Science And Technology) E 1z2731
October 2019 62
....importance Of Quality Circles - Hdfc 3d4o3s
December 2019 44
Ranbaxy Balance Sheet 2u116j
December 2019 60
Types Of Switches.pdf 3n4k1f
October 2022 0
30 Easy Methods Astral Travelling 1w1i60
December 2019 61